Hong-Jie Shen Selected Research

Chimeric Antigen Receptors

1/2022

Successful application of PD-1 knockdown CLL-1 CAR-T therapy in two AML patients with post-transplant relapse and failure of anti-CD38 CAR-T cell treatment.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hong-Jie Shen Research Topics

Disease

3	Neoplasms (Cancer) 01/2022 - 01/2013
3	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2022 - 12/2011
3	Leukemia 01/2013 - 11/2009
2	Infections 01/2022 - 01/2022
2	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 08/2014 - 10/2008
1	Latent Infection 01/2022
1	Brain Diseases (Brain Disorder) 01/2022
1	Herpesviridae Infections (Herpesvirus Infection) 01/2020
1	Neoplasm Metastasis (Metastasis) 01/2019
1	Triple Negative Breast Neoplasms 01/2019
1	Philadelphia Chromosome 08/2014
1	Macular Edema 01/2014
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 06/2010
1	Polycythemia Vera 02/2009
1	Primary Myelofibrosis (Myelosclerosis) 02/2009
1	Myeloproliferative Disorders (Myeloproliferative Disorder) 02/2009
1	Residual Neoplasm 10/2008

Drug/Important Bio-Agent (IBA)

4	Messenger RNA (mRNA)IBA 01/2022 - 02/2009
3	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2018
2	Polysaccharides (Glycans)IBA 01/2013 - 12/2011
2	GlycosyltransferasesIBA 01/2013 - 12/2011
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 01/2022
1	Chimeric Antigen ReceptorsIBA 01/2022
1	Apolipoproteins E (ApoE)IBA 01/2022
1	Antiviral Agents (Antivirals)IBA 01/2020
1	fms-Like Tyrosine Kinase 3IBA 01/2020
1	UbiquitinIBA 01/2019
1	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2019
1	Long Noncoding RNAIBA 01/2019
1	RNA Splicing FactorsIBA 01/2018
1	RNA-Binding Proteins (RNA-Binding Protein)IBA 01/2018
1	Tyrosine Kinase InhibitorsIBA 08/2014
1	Uracil-DNA GlycosidaseIBA 08/2014
1	Phosphotransferases (Kinase)IBA 08/2014
1	Bevacizumab (Avastin)FDA Link 01/2014
1	GalactosyltransferasesIBA 01/2013
1	CarbohydratesIBA 01/2013
1	AntigensIBA 01/2013
1	Carbohydrate Tumor-Associated Antigens (Antigens, Tumor-Associated Carbohydrate)IBA 01/2013
1	Imatinib Mesylate (Gleevec)FDA Link 01/2013
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 12/2011
1	EnzymesIBA 12/2011
1	Dimethyl Sulfoxide (DMSO)FDA LinkGeneric 12/2011
1	poly-N-acetyllactosamineIBA 12/2011
1	GlycosphingolipidsIBA 12/2011
1	Monoclonal AntibodiesIBA 06/2010
1	beta-Galactosidase (Lactaid)IBA 11/2009
1	Hemoglobins (Hemoglobin)IBA 02/2009
1	RNA (Ribonucleic Acid)IBA 02/2009
1	Immunoglobulins (Immunoglobulin)IBA 10/2008
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 10/2008

Therapy/Procedure

1	Drug Therapy (Chemotherapy) 01/2022
1	Therapeutics 01/2022
1	Light Coagulation 01/2014